Dr. Sarasa Kimata, MD

Dr. Kimata practices at Kaiser Permanente South San Francisco Medical Center in South San Francisco, California, part of Kaiser Permanente.

Dr. Kimata's NPI, 1477631232, was assigned on November 1, 2006. Dr. Kimata graduated from The Warren Alpert Medical School of Brown University in 2000. Dr. Kimata holds California license A90862.

Dr. Kimata's primary practice is Kaiser Permanente South San Francisco Medical Center, at 1200 El Camino Real, South San Francisco, CA 94080 in San Mateo County. The practice phone is (650) 742-3200.

Dr. Kimata's primary practice is Kaiser Permanente South San Francisco Medical Center in South San Francisco, California, part of Kaiser Permanente. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Kimata to 1 more dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kimata practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kimata's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kimata is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kimata's licenses on file in 3 states: California, New York and Pennsylvania.

Dmand AI lists chronic kidney disease and fluid and electrolyte imbalances among the conditions Dr. Kimata treats.

CMS data shows 26 Medicare services from Dr. Kimata across 1 procedure code in 2024, for 24 Medicare patients. Medicare paid $1,813 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 24 Medicare patients who saw Dr. Kimata in 2024. 75% of them have chronic kidney disease, and 75% have diabetes. 46% are also on Medicaid. Their average risk score is 6.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kimata's median patient age at 69, with 37% women.

In 2024, Dr. Kimata wrote 1,250 Medicare Part D claims for 232 patients. 85% of them were for generic drugs. CMS names the drug for 1,016 of them, across 23 drugs with 11 or more claims each, at $161,058 in total drug cost. In 2023, CMS named 984 claims across 25 drugs.

Dr. Kimata accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kimata as offering telehealth.

CMS Open Payments shows 1 general payment to Dr. Kimata from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. NxStage Medical, Inc. paid the most, $27.

Dmand AI lists 1 award for Dr. Kimata, most recently CMS Stage 1 2012 in 2011.

Dr. Kimata graduated from The Warren Alpert Medical School of Brown University in 2000.

Dr. Kimata is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.